Trials / Completed
CompletedNCT01014078
A Four Week Study of Azithromycin Ophthalmic Solution, 1% Versus Placebo in Subjects With Dry Eye Disease
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 112 (actual)
- Sponsor
- Merck Sharp & Dohme LLC · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to compare the safety and efficacy of azithromycin ophthalmic solution, 1% in dry eye subjects over a four week treatment period, using placebo as a comparison.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Azithromycin Ophthalmic Solution, 1% | 1 drop BID for the first 2 days and then 1 drop once a day for the remainder of the study (29 ± 1 days) |
| DRUG | Placebo | 1 drop BID for the first 2 days and then 1 drop once a day for the remainder of the study (29 ± 1 days) |
Timeline
- Start date
- 2009-10-01
- Primary completion
- 2010-03-01
- Completion
- 2010-03-01
- First posted
- 2009-11-16
- Last updated
- 2011-09-26
Locations
9 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01014078. Inclusion in this directory is not an endorsement.